By Josh White
Date: Friday 04 Oct 2019
(Sharecast News) - Liquid biopsy company Angle announced on Friday that the Queen Mary University of London (QMUL) European patent covering the measurement of the number of megakaryocytes in a patient blood sample as an assessment of the prognosis for prostate cancer has been granted.
By Josh White
Date: Thursday 29 Aug 2019
(Sharecast News) - Liquid biopsy company Angle announced on Friday that the main phase of its 200-patient ovarian cancer clinical verification study has been initiated and the first patient has been enrolled.
By Iain Gilbert
Date: Tuesday 25 Jun 2019
(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.
|Angle upbeat on recent cancer research results||21-Jun-2019||ShareCast|
|Angle reveals positive results from latest Parso...||31-May-2019||ShareCast|
|Angle's Parsortix system used in more groundbrea...||26-Apr-2019||ShareCast|
|Angle's Parsortix to be used in new Greece study||12-Apr-2019||ShareCast|
|Angle completes enrolment in Parsortix breast ca...||07-Mar-2019||ShareCast|
|Angle client demonstrates new use for 'Parsortix...||25-Feb-2019||ShareCast|
|Angle's 'Parsortix' used in new groundbreaking c...||11-Feb-2019||ShareCast|
|Angle sees 'highly encouraging' results from pre...||29-Oct-2018||ShareCast|
|Angle makes 'good progress' with ANG-002 patient...||25-Oct-2018||ShareCast|
|Angle optimises first ever workflow to culture C...||19-Apr-2018||ShareCast|
|Angle PMT test out-performs in diagnosing ovaria...||26-Mar-2018||ShareCast|
|Angle reaches provisional agreement with Abbott||06-Feb-2018||ShareCast|
|ANGLE confirms recent positive Parsortix tests||08-Dec-2017||ShareCast|
|Angle upbeat on latest Parsortix study||28-Nov-2017||ShareCast|
|Angle completes fundraising and acquisition of ...||01-Nov-2017||ShareCast|
|Angle's Parsortix system is strongest performer ...||17-Oct-2017||ShareCast|
|Angle extends fundraising after investor suffers...||12-Oct-2017||ShareCast|
|52 Week High||83.50p|
|52 Week Low||38.00p|
Compare performance with the sector and the market.